Premium
Mitral valve surgery combined with on‐pump versus off‐pump myocardial revascularization: A prospective randomized analysis with midterm follow‐up
Author(s) -
Zavolozhin Alexey,
Shonbin Alexey,
Bystrov Dmitry,
Enginoev Soslan
Publication year - 2020
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/jocs.14861
Subject(s) - medicine , revascularization , randomized controlled trial , myocardial revascularization , cardiology , prospective cohort study , surgery , myocardial infarction
Background The aim of the study was to compare results off‐pump coronary artery bypass (OPCAB) combined mitral valve reconstruction (MVR) with standard on‐pump approach. Methods From January 2014 to December 2017, a total of 53 patients received a combined myocardial revascularization and MVR for multivessel coronary artery disease (CAD) complicated by severe ischemic mitral regurgitation (IMR). All the subjects were divided into two groups: group I: 27 patients, received OPCAB + MVR, and group II (control group): 26 patients with on‐pump myocardial revascularization (ONCAB) + MVR. Results The aortic cross‐clamp (ACC) and cardio‐pulmonary bypass (CPB) times were longer in group II, 47.0 (44.0; 55.0) vs 94.5 (89.75; 105.5) minutes, P < .05 and 70.0 (63.0; 77.0) vs 138.5 (127.0; 157.5) minutes, P < .05, respectively. Evaluation of major clinical events showed that the implementation of the off‐pump stage of myocardial revascularization in patients with severe IMR did not lead to significant changes in the mortality and postoperative complications. Furthermore, its use did not affect the volume of blood loss and need for blood transfusion, the duration of mechanical ventilation, the need for inotropic therapy, as well as the duration of the patient's resuscitation and the total duration of hospitalization, with the one exception: the troponin‐T level increase in the OPCAB + MVR group was less than in the ONCAB + MVR group. Conclusion OPCAB combined MVR in patients with CAD and severe IMR can be performed with shorter CPB and ACC times, and lower troponin‐T level after surgery, without reducing the risk of surgical complications.